Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(CSE:METX)

2.800 UNCHANGED
Delayed Quote Updated: 2:14 PM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about METX

News headline image
ME Therapeutics Extends Option Agreement for CD22 Nanobody Asset
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics to Pitch at CSE Capital Tech Connect During Web Summit Vancouver
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics Provides Scientific Update on In Vivo CAR and Therapeutic mRNA Programs
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics Scientific and Corporate Update
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics Attending JP Morgan Healthcare Conference
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics Granted Licence for CD22 Nanobody Asset to Expand Next-Gen In Vivo CAR Cell Therapy Program
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics Added to CSE25 Index
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics Secures U.S. Patent for Lead Candidate and Advances Broader Therapeutic Programs
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics Receives Support to Advance mRNA Therapeutic Candidates for Cancer and Inflammatory Disease
From ME Therapeutics Holdings Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>